SGLT2 Inhibitor Therapy in Patients With Transthyretin Amyloid CardiomyopathyAldostefano Porcari, Marianna Fontana, Luca Bordignon et al.|Journal of the American College of Cardiology|2024Cited by 137
Incidence and risk factors for pacemaker implantation in light‐chain and transthyretin cardiac amyloidosisAldostefano Porcari, Marco Merlo, Maddalena Rossi et al.|European Journal of Heart Failure|2022Cited by 69
Low QRS Voltages in Cardiac AmyloidosisAlberto Cipriani, Claudio Rapezzi, Laura De Michieli et al.|JACC CardioOncology|2022Cited by 67